AbbVie | ABBV - Ebit

Stock Price
227.68
Daily Change
2.04 0.90%
Monthly
3.41%
Yearly
19.86%
Q1 Forecast
216.14

AbbVie reported $5.72B in EBIT for its fiscal quarter ending in June of 2025.





Ebit Change Date
AbbVie USD 5.72B 69M Jun/2025
Abbott USD 2.54B 358M Dec/2025
ALKERMES USD 89.08M 3.9M Sep/2025
Amgen USD 4.43B 2.17B Sep/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Biogen USD 659.6M 157M Sep/2025
BioMarin Pharmaceutical USD -31.69M 308.58M Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Eisai JPY 13.67B 7.07B Sep/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Gilead Sciences USD 3.51B 810M Sep/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
J&J USD 5.11B 2.3B Dec/2025
Medtronic USD 1.7B 100M Sep/2025
Merck USD 7.56B 1.19B Sep/2025
Neurocrine Biosciences USD 239.3M 93.7M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Pfizer USD 4.57B 1.97B Sep/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 502M 168M Dec/2024
Ultragenyx Pharmaceutical USD -170.89M 22.68M Sep/2025
United Therapeutics USD 389.3M 112.4M Sep/2025
Vertex Pharmaceuticals USD 1.24B 84.6M Sep/2025
Zoetis USD 975M 40M Sep/2025